MedTech AI Daily is the morning briefing for commercial leaders, marketing executives, and heads of growth in medical devices who need to separate signal from noise on AI.
In 10 minutes, we cover how AI is changing the business of selling, not just the science of building:
• AI in commercial strategy
How leading manufacturers use AI to modernize targeting, field execution, and marketing.
• Regulatory moves that matter
What FDA AI/ML clearances mean for speed to market and how they change launch planning.
• Digital transformation in practice
Real use cases of generative AI in HCP engagement, field enablement, and patient adoption.
• Market moves to watch
M&A, partnerships, and competitor initiatives that define where digital health is heading next.
You get practical intelligence you can use in your pipeline, plans, and board decks. Not demo theater.
Hosted by Stan Berteloot
All content for MedTech AI Daily: The Commercial Brief is the property of Stan Berteloot and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
MedTech AI Daily is the morning briefing for commercial leaders, marketing executives, and heads of growth in medical devices who need to separate signal from noise on AI.
In 10 minutes, we cover how AI is changing the business of selling, not just the science of building:
• AI in commercial strategy
How leading manufacturers use AI to modernize targeting, field execution, and marketing.
• Regulatory moves that matter
What FDA AI/ML clearances mean for speed to market and how they change launch planning.
• Digital transformation in practice
Real use cases of generative AI in HCP engagement, field enablement, and patient adoption.
• Market moves to watch
M&A, partnerships, and competitor initiatives that define where digital health is heading next.
You get practical intelligence you can use in your pipeline, plans, and board decks. Not demo theater.
Hosted by Stan Berteloot
"Pfizer's Sickle Cell Setbacks, Viking Therapeutics' Weight Loss Success, and the Rise of AI in Healthcare"
MedTech AI Daily: The Commercial Brief
3 minutes
1 year ago
"Pfizer's Sickle Cell Setbacks, Viking Therapeutics' Weight Loss Success, and the Rise of AI in Healthcare"
"AI in Life Sciences" is a podcast that dives into the latest happenings and innovations in the life sciences industry. In today's episode, we discuss Pfizer's decision to end one of its clinical trials focused on a sickle cell treatment, and how it would affect their plans for the drug's approval. We'll also delve into new obesity data from Viking Therapeutics, and how their dual agonist, VK2735, has shown promising results in weight reduction.
The importance of high-quality data in AI projects cannot be undervalued, and we take a closer look at how 'data health' is pivotal to the success of AI innovations. Furthermore, we explore a groundbreaking gene therapy by Nanoscope Therapeutics, that is offering hope to millions suffering from retinal diseases.
As the Supreme Court deliberates on the in-person dispensing requirement for mifepristone, we consider its potential impact on the biopharma industry and reproductive rights. And lastly, we shed light on the rise of AI-integrated medical devices that are redefining the healthcare sector. Tune in to get the latest updates from the world of life sciences.
MedTech AI Daily: The Commercial Brief
MedTech AI Daily is the morning briefing for commercial leaders, marketing executives, and heads of growth in medical devices who need to separate signal from noise on AI.
In 10 minutes, we cover how AI is changing the business of selling, not just the science of building:
• AI in commercial strategy
How leading manufacturers use AI to modernize targeting, field execution, and marketing.
• Regulatory moves that matter
What FDA AI/ML clearances mean for speed to market and how they change launch planning.
• Digital transformation in practice
Real use cases of generative AI in HCP engagement, field enablement, and patient adoption.
• Market moves to watch
M&A, partnerships, and competitor initiatives that define where digital health is heading next.
You get practical intelligence you can use in your pipeline, plans, and board decks. Not demo theater.
Hosted by Stan Berteloot
